The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Lol these guys have done a runner for sure
This is seperate from the funding I mentioned. Combine this though and it's 30+mil over a year and a half with no results.
I don't remember reading that. Not sure what I'd rather though, disappointing if they have just sat on the money and haven't progressed anything but also disappointing if they have applied for emergency use in India and the other countries haven't gotten any decent results.
Can only hope the money has been used and we see the benefits of it asap
We had AUD10.6mil in December as well and not a single thing came from it. From the AUD 11m6mil from the LSE IPO there was what? Completion of one trial which was already ongoing and ended up being a a piece of what it was ment to be (cognicann)
Isn't this the 3rd data collecting app that they have launched?: Never heard of the others again
Irontaz and all his crap he spreads.
I actually wouldn't be surprised if it was Roby as they both just talk ****.
Oh lord not this bloke again...
Mornington read it in this article months ago.
https://www.google.com/amp/s/stockhead.com.au/health/this-fundie-reckons-mgc-pharma-can-soar-well-over-3x-current-share-price/%3famp
He has failed to understand the following quote and has carried on with this nonsense for months now misleading lots who read his posts.
"This article was developed in collaboration with MGC Pharma, a Stockhead advertiser at the time of publishing."
Yes this article was published 19th may 2022. The trial results were released to the market 15 December 2020.
This trial is done and as this write up suggests "Future studies are warranted" which is what we aren't hearing about.
But no, go ahead and celebrate the same thing over and over again. It's an MGC special.
This isn't news? Its old. This trial happened early last year and they already released results. Just another fluff piece which is being reflected appropriately in the share price.
They need to release date on current trials not old trials.
CogniCann trials just wrapped up with results due "mid year" Only 20 patients though
Are you just talking to yourself on here?
So MGC have gone around the emergency use authorization and can now sell cimetra in india?
"A Phase II Clinical Trial undertaken by the University of Notre Dame in Western Australia has recently concluded"
Hopefully these results are published sooner rather than later
Quarterly report should be out today. Hopefully it's kind to us
Magstar seems to have a sook whenever any body points out MGC/Robys bull****. Either they are an emotional investor or are working for MGC...maybe as Robys advisor who keeps feeding him this Pfizer crap.
Or Robys wanna be lover
“The waters have been muddied by the variety of commercially oriented wellness products that have nothing to do with true medicine,” Zomer added.
Ahh Roby wtf is extrax then you clown
Sciensus Rare actually looks to be well established...Hopefully this company can produce for MGC as AMC seems to be a dud.
The page in this link was posted on March 10th but in the interview Ron says something like "we were first to list on the lse this year in 2021"
Looking at their trials graph towards the end of the interview it says that CogniCann and CannEpil results are due in April.
So question is do we think this is an old interview the page has used or was it actually filmed recently and results for trials aren't far away?
Throught the company as well...